ORIGINAL RESEARCH article
Front. Cell Dev. Biol.
Sec. Cell Death and Survival
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1684620
This article is part of the Research TopicMechanisms and Therapeutic Strategies in Cellular Injury and RepairView all 7 articles
Non-Invasive Imaging Biomarkers of Cellular Injury and Proliferation in Nasopharyngeal Carcinoma: Insights from Multiparametric MRI
Provisionally accepted- 1Department of Radiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, China
- 2Institute of Medical Imaging, China Three Gorges University, Yichang, China
- 3Department of Nuclear Medicine, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 4Department of Pathology, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, China
- 5Department of Oncology, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Early identification of therapeutic response and tumor proliferative status is essential in nasopharyngeal carcinoma (NPC). Multiparametric MRI-combining IVIM and DCE-provides quantitative biomarkers reflecting tissue diffusion, perfusion, and vascular permeability. We evaluated whether pretreatment IVIM-and DCE-derived parameters predict short-term response to induction chemotherapy plus concurrent chemoradiotherapy and whether they correlate with tumor proliferation (Ki-67). Methods: In this prospective study (n = 48; January 2021–January 2023), IVIM parameters (D, D*, f) and DCE parameters (Ktrans, Kep, Ve, Vp) were quantified before treatment. Treatment response at 6 months was classified by RECIST 1.1 as complete response (CR) or non-CR. Ki-67 index was determined by immunohistochemistry (cutoff 50%). Group comparisons used t-tests or Mann–Whitney U tests; logistic regression identified independent predictors; ROC analysis evaluated diagnostic performance; Spearman correlation tested associations with Ki-67. Results: Pre-treatment D was lower in the CR group (0.82 ± 0.12 vs. 0.92 ± 0.11 ×10^-3 mm^2/s; P = 0.007). Ktrans and Kep were higher in CR (0.95 ± 0.34 vs. 0.30 ± 0.31 min^-1, P = 0.014; 0.16 ± 0.09 vs. 0.11 ± 0.06 min^-1, P = 0.025). D was an independent predictor (P = 0.008). The combined model (D + Ktrans + Kep) yielded AUC = 0.834 (sensitivity 90.0%; specificity 61.4%). Ki-67 correlated negatively with D (r = -0.329, P = 0.022) and positively with Vp (r = 0.292, P = 0.044). Conclusion: Multiparametric MRI can noninvasively predict short-term response and reflect proliferative status in NPC. Integrating IVIM-derived D with DCE-derived Ktrans and Kep improves early prediction of treatment efficacy; Vp may serve as an imaging surrogate for proliferation.
Keywords: Cellular injury, Proliferation biomarker, intravoxel incoherent motion (IVIM), Dynamic contrast-enhanced MRI (DCE-MRI), Ki-67, nasopharyngeal carcinoma
Received: 12 Aug 2025; Accepted: 22 Oct 2025.
Copyright: © 2025 Zhao, Xie, He, Xiong, Yu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Chengxin Yu, ycyucx@163.com
Yang Liu, 799132440@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.